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Mitochondrial quantity and density are associated with increased
oxidative metabolism. It has been demonstrated that a hypocaloric
high fat/low carbohydrate (HF/LC) diet can up-regulate transcrip-
tional markers of mitochondrial biogenesis; this was yet to be
explored in vivo subsequent to a high protein/low carbohydrate
(HP/LC) diet. Thus the aims of the study were to explore such diets
on transcriptional markers or mitochondrial biogenesis, body
composition and resting metabolic rate (RMR). Forty-ﬁve healthy
male participants were randomly assigned one of four intervention
diets: eucaloric high protein low carbohydrate (PRO-EM), hypo-
caloric high protein low carbohydrate (PRO-ER), eucaloric high
carbohydrate (CHO-EM) or hypocaloric high carbohydrate (CHO-
ER). The macronutrient ratio of the high protein diet and high
carbohydrate diets was 40:30:30% and 10:60:30% (PRO:CHO:FAT)
respectively. Energy intake for the hypocaloric diets were calcu-
lated to match resting metabolic rate. Participants visited the
laboratory on 3 occasions each separated by 7 days. On each visit
body composition, resting metabolic rate and a muscle biopsy
from the vastus lateralis was collected. Prior to visit 1 and 2nce Lab, Unit 2 Brentside Executive Park, Great West Road, Brentford,
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M. Furber et al. / Clinical Nutrition Experimental 14 (2017) 13e2514habitual diet was consumed which was used as a control, between
visit 2 and 3 the intervention diet was consumed continuously for
7-days. No group  time effect was observed, however in the
PRO-ER group a signiﬁcant increase in AMPK, PGC-1a, SIRT1 and
SIRT3 mRNA expression was observed post diet intervention
groups (p < 0.05). No change was observed in any of the tran-
scriptional markers in the other 3 groups. Despite ~30% reduction
in calorie intake no difference in lean mass (LM) loss was observed
between the PRO-ER and CHO-EM groups. The results from this
study suggest that a 7-day a high protein low carbohydrate
hypocaloric diet increased AMPK, SIRT1 and PGC-1 a mRNA
expression at rest, and also suggest that increased dietary protein
may attenuate LM mass loss in a hypocaloric state.
© 2017 The Authors. Published by Elsevier Ltd on behalf of
European Society for Clinical Nutrition and Metabolism. This is an
open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Mitochondria are responsible for energy production via fatty-acid oxidation, Krebs cycle and
oxidative phosphorylation. Mitochondria quantity and density has been linked with increased
endurance performance [27], reduction in type 2 diabetes and improved insulin sensitivity
[5,17,21,24,25]. A seminal paper from [28] ﬁrst described peroxisome proliferator-activated receptor
gamma coactivator 1-alpha (PGC1-a), in the subsequent years PGC-1a had been identiﬁed as key for
the regulation and co-activation of mitochondrial biogenesis [18].
Both AMP-activated protein kinase (AMPK) and silent information regulator T1 (SIRT1) mediated
deacetylation [10] have been demonstrated to regulate expression of PGC-1a in human muscle [30]. A
substantial body of evidence suggests that SIRT1 expression responds to decreases in nutrient avail-
ability [23] and increases in energy expenditure [36]. Similarly AMPK is stimulated by cellular stressors
that causes a depletion of adenosine triphosphate (ATP) and elevation of AMP, such as calorie re-
striction [13], hypoglycaemia [13] and exercise [9]. Subsequently, increases in PGC-1a mRNA expres-
sion can be observed in direct response to such stressors [13]. Acute hypocaloric HF/LC diets (50% fat,
30% carbohydrate and 20%, protein) signiﬁcantly increases AMPK phosphorylation and PGC-1a
deacetylation, this is not observed subsequent a hypocaloric low fat high carbohydrate (LF/HC) diet
(20:60:20%) [6], suggesting increased dietary carbohydrate intake prevents the activation of the AMPK/
SIRT e PGC-1a axis in skeletal muscle that would otherwise be activated by a low calorie diet.
The preservation of lean mass is important for the maintenance of quality of life [14], it is generally
accepted that weight loss strategies which preserve LM are preferential to those that results in skeletal
muscle atrophy [33]. During hypocaloric diet-induced weight loss approximately 20e30% of mass lost
is lean mass (LM) [1], increasing dietary protein is one method which has been demonstrated to
attenuate skeletal muscle atrophy in a hypocaloric state [35]. The manipulation of carbohydrate intake
as a regulator of weight maintenance/loss is well documented demonstrating improved lipid proﬁle
and fat oxidation [2,12]. However, the majority of literature manipulates dietary fat e protein remains
constant. A small number of metabolic perturbation murine studies have manipulated protein intake
and it has been shown that high protein intake (35% protein) increases PGC-1a expression relative to a
control diet (15% protein) [22]. Furthermore in periods of energy deﬁciency it has been demonstrated
that resting metabolic rate can be reduced [8], and in overweight and obese individuals attempting to
lose weight, dietary restriction can result in decreases in muscle mass which may down-regulate the
metabolic process, compromising healthy weight management [29,32]. Increased protein intake in
periods of energy restriction may support the maintenance of metabolic rate [4].
In this ﬁeld most research focuses on increasing dietary fat to restrict carbohydrate intake. However
it is well documented that an increased protein intake can attenuate LM loss and may be a preferable
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markers of mitochondrial biogenesis is not fully explored. This study was designed to investigate the
impact of a high protein low carbohydrate diet independently andwith calorie restriction onmetabolic
adaptation, body composition and RMR.2. Materials and methods
2.1. Participants
Forty-eight healthy males volunteered to participate in the study with forty-ﬁve completing (Table
1). One participant was removed due to non-dietary adherence and two did not complete the study.
Participants were initially screened against pre-determined criteria to ensure they met the inclusion
criteria and were free from any medical condition that would preclude participation in the study. Par-
ticipants could not be following a restrictive dietary regime (vegetarian, vegan) or suffer from any food
allergies/intolerances. Participants could not be participating in physical activity>2 times perweek and
could not be consuming or have consumed any dietary or protein supplements in the previous 2weeks.
The experimental procedures and potential risks associated with the study were explained and the
participants gavewritten informed consent prior to participation. None of the participants had a history
of anyneurological disease ormusculoskeletal abnormality. The studywas approvedby theUniversityof
Hertfordshire School of Life and Medical Sciences ethics committee LMS/PG/UH/00196.
2.2. Study protocol
In a randomised repeated-measures parallel group study design, the participants were assigned to
one of four groups: energy matched high protein (PRO-EM), energy restricted high protein (PRO-ER),
energy matched high carbohydrate (CHO-EM) or energy restricted high carbohydrate (CHO-ER) (Table
2). The participants attended the laboratory on three occasions, each separated by 7 days. Before visit 1
(baseline) and visit 2 (pre) all participants remained on their habitual diet, between visits 2 and visit 3
(post) the participants consumed the randomly assigned intervention diet. All experimental proced-
ures were completed in the same order at the same time of the day. The baseline and pre assessments
were used as a control to demonstrate stability of the measures assessed, where no differences were
observed between these measures the pre measures were used for analysis.
2.3. Experimental protocol
Following an overnight fast the participants arrived at their allocated timeslot (start time range:
07:30e09:30 am) each testing visit. The participants were requested to arrive at the laboratory using
the same mode of transport. Morning physical activity was not permitted. Prior to the pre and baseline
visits the participants were completed a standardised 4 day food dairy. The food diary was visually
assessed for accuracy by the investigator and further detail was requested if required. An assessment of
body composition (DXA scan) was then undertaken, followed by themeasurement of resting metabolic
rate. Finally a micro-muscle biopsy was collected (Fig. 1).Table 1
Group participant characteristics.
n Age Weight Height BMI
PRO-EM 11 24.9 ± 6.1 73.3 ± 14.4 180.3 ± 7.0 22.4 ± 3.4
PRO-ER 12 27.4 ± 6.0 77.1 ± 7.9 179.3 ± 5.2 24.0 ± 2.4
CHO-EM 12 25.3 ± 5.1 74.0 ± 10.5 179.0 ± 6.9 23.1 ± 3.0
CHO-ER 10 26.1 ± 3.9 73.4 ± 7.4 179.4 ± 5.2 22.8 ± 1.9
Table 2
Prescribed macronutrient breakdown for each group.
Prescribed caloriﬁc intake Carbohydrate (%) Protein (%) Fat (%)
PRO-EM Matched to estimated daily energy requirements 30 40 30
PRO-ER Restricted to resting metabolic rate 30 40 30
CHO-EM Matched to estimated daily energy requirements 60 10 30
CHO-ER Restricted to resting metabolic rate 60 10 30
(% ¼ percentage of total daily caloriﬁc intake).
Visit 1
Control Visit
Day 1
DXA scan
GEM assessment
Micro muscle-
biopsy
Habitual diet
4-day food diary Intervenon diet
Screening, 
brieﬁng and 
document 
provision
Visit 7
Control Visit
Day 8
Visit 3
Post intervenon Visit
Day 15
Habitual diet
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Fig. 1. Schematic of experimental protocol.
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A 4 day food diary using estimated household measures was used to collect habitual dietary intake
prior to the pre and baseline visits. In the study brieﬁng the participants were provided with a
comprehensive example of the food diary and were instructed on how to complete it. The importance
of accuracy and detail were emphasised, as was the importance of maintaining current dietary habits
and documenting all food and drink consumed. Participants were requested to record intake on 3week
days and 1 weekend day each week, a total of 8 days dietary intake was collected over the 2 week prior
visit 1 and visit 2.
2.5. Body composition assessment: dual energy X-ray absorptiometry (DXA) scan
All metal and piercings were removed and fasted body mass (BM) was measured using a digital
column scale (seca 704, seca Ltd., Hamburg, Germany). A full body DXA scan (GE Lunar iDXA, GE
Healthcare, UK) was performed in accordance with the manufacturer's guidelines for patient posi-
tioning and was analysed using enCORE Software, version 14.10 (GE Healthcare, Bucks, UK). The scan
measured BM, total LM and total fat mass (FM). All scans were performed by a fully trained operator. In
addition to regular machine calibration, a standard quality assurance procedure was performed each
testing day.
2.6. Resting metabolic rate (RMR)
RMR was measured using indirect calorimetry (coefﬁcient of variation ¼ 1.48%). All assessments
were completed in a temperature controlled environmental chamber (temperature set to 24 C). The
participants arrived at the laboratory in themorning following an overnight fast. The participants were
requested to expel as little energy as possible prior to arrival. The participant lay in a supine position on
a couch and a large towel was placed over their body to maintain comfort. Once comfortable a
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participants head. The participant was instructed to relax, breathe normally and not to move or fall
asleep. The GEM was set to collect respiratory bins every 60 s for 20 min, the data analysed was from
the ﬁnal 5 min of collection. Throughout the test the participant was observed through a window to
check for adherence. RMR was calculated using the modiﬁed Weir equation [39]:
“RMR ¼ 1.44  (3.9  V
,
O2 þ 1.1  V
,
CO2)”
Respiratory exchange ratio was calculated to assess for changes in resting substrate utilisation by
dividing theV
,
CO2 value (L$min1) by the V
,
O2 value (L$min1) from each minute bin collected on the
GEM.
2.7. Micro muscle biopsy
Muscle biopsies were obtained from the midpoint on the lateral aspect of the right vastus lateralis
muscle. The biopsy site was cleaned using Betadine (Pardue Products, USA) and samples were obtained
under local anaesthesia, 2 ml of 1% v/v without adrenaline Lidocaine Hydrochloride (Hameln Phar-
maceuticals: cat. no PL01502) was injected into the subcutaneous fat of the selected biopsy site. Once
the anaesthetic had taken effect (~5 min), a 14 gauge co-axial was inserted ~2 cm into the muscle, a
disposable core biopsy instrument (TSK Stericut Biopsy Needle 14 Gauge, TSK Laboratories, Japan) was
then inserted through the co-axial and activated. A single biopsy pass was used collecting approxi-
mately 10e20 mg of muscle tissue. The biopsy instrument was immediately removed from the leg and
within 10 s the muscle tissue was removed from the biopsy instrument using a sterile scalpel and ﬂash
frozen in liquid nitrogen. The muscle sample was placed in an RNAse free plastic vial and stored at80
OC under the HTA license number 12202 until analysis.
2.8. Dietary prescription
For the two energy restricted (ER) groups the participants were provided an intervention diet with
an energy intake that met RMR. RMR was calculated from the GEM result attained from Visit 1. For the
energy matched (EM) groups, energy intake was calculated according the World Health Organisation
[40] lifestyle dependent physical activity multiplier:
“EI ¼ PAF  RMR”
EI ¼ Energy intake, PAF ¼ physical activity factor, RMR ¼ resting metabolic rate
RMRwas attained from the GEM result on visit 1, and PAF was selected following a series of lifestyle
questions concerning daily activity levels, type of work and exercise activity (Table 3).
A total of 34 (17 high carbohydrate, 17 high protein) different diet menus were created starting at
1075 kcal, increasing by 150 kcal for each different diet up to 3325 kcal. Participants were assigned the
diet closest to their calculated interventional energy intake. The greatest difference between estimated
intervention diet and prescribed diet was 75 kcal per day.Table 3
Lifestyle dependent physical activity multiplier used to
calculate energy intake [40].
Activity level Calculation
Low 1.53  RMR
Moderate 1.77  RMR
Active 2.25  RMR
M. Furber et al. / Clinical Nutrition Experimental 14 (2017) 13e2518All intervention meals were created by Soulmatefood® (Waterfoot, Lancashire, UK) and directly
delivered to the participant's door (Table 4). Each participant received two deliveries; the ﬁrst delivery
contained three day's food, the second four day's food. Each day consisted of 5 pre packaged/cooked
meals (breakfast, morning snack, lunch, afternoon snack and dinner). Included with the delivery was a
daily menu with consumption instructions. The participants were required to refrain from consuming
any additional food and just drink water or ﬂuids free from caffeine or energy.
2.9. Quantitative PCR (qPCR)
2.9.1. RNA Isolation
Human muscle biopsies were homogenised in 700 mL MagNA Pure LC RNA Isolation Tissue Lysis
buffer (Roche, Mannheim, Germany) in Roche MagNA Lyser Green bead tubes at 6500 rpm for 30 s.
After homogenisation, the tubes were centrifuged for 10 min at 13,000g before 350 mL of each ho-
mogenatewas used for RNA extraction. Total RNAwas extracted using the MagNA Pure 96 Cellular RNA
Large Volume Kit on a MagNA Pure 96 (Roche, Mannheim, Germany), in an elution volume of 50 mL
according to the manufacturer's protocol. RNA was stored at 80 C. RNA concentrations were
determined (A260) using a NanoQuant plate on a Tecan Inﬁnite 200PRO. RNA quality (RNA integrity
number equivalent, RINe) was assessed using RNA ScreenTape on a 2200 TapeStation (Agilent, Santa
Clara, USA).
2.9.2. Reverse transcription
As a result of the large sample number and the automated process, RNA concentration was not
taken into account for each individual reaction. 14 mL of each RNA sample was reverse transcribed in a
total volume of 20 mL using the High capacity cDNA reverse transcription kit (without RNase inhibitor,
Applied Biosystems, Thermo Fisher, Loughborough, UK). The average RNA concentration across the 142
samples was 32.4 ng$mL1 equating to an average of 453 ng RNA/reverse transcription reaction. Re-
actions were performed in 96 well PCR plates on a PTC-225 Peltier thermal cycler (MJ Research,
Quebec, Canada) using the following proﬁle; 25 C for 10 min, 37 C for 60 min, 85 C for 5 min, 4 C
hold. Minus RTcontrol reactions were set up for 14 samples, inwhich the RNA componentwas replaced
with nuclease free water (Ambion, Fisher Scientiﬁc, Loughborough, UK).
2.9.3. qPCR
For quantitative real-time PCR (qPCR), Human TaqMan® gene expression assays were purchased as
a 20 assay ready stock from Life Technologies (Carlsbad, USA) (primers 18 mM and probes 5 mM)
(Table 5). 1 mL cDNA was added to each qPCR reaction mixture which also contained gene expression
assay mix (primers 900 nM ﬁnal, probe 250 nM ﬁnal), LightCycler 480 Probes Master and nuclease free
water to give a 5 mL total reaction volume. Reactions were prepared in white multiwell 384 plates
(Roche, Mannheim, German) using aMosquito HV (TTP Labtech, Melbourn, UK). The plates were sealed
using optical seals (Roche, Mannheim, Germany) and centrifuged at 290g for 2 min before being run on
a LightCycler® 480 instrument (Roche, Mannheim, Germany) with the following thermal cycling pa-
rameters: initial de-naturation step 95 C for 10 min, followed by 45 cycles of denaturation at 95 C for
10 s and primer annealing/extension at 60 C for 30 s. A cooling step at 40 C for 30 s was the ﬁnal stage
of the run.Table 4
Prescribed daily calorie intake and macronutrient breakdown for each group throughout the 7-day intervention.
Group Dietary intake (kcal$day1) CHO ($day1) PRO ($day1) FAT ($day1)
g g$kg1 g g$kg1 g g$kg1
PRO-EM 2828 ± 331 217 ± 26 3.0 ± 0.5 289 ± 34 4.0 ± 0.7 96 ± 11 1.3 ± 0.2
PRO-ER 1876 ± 116 143 ± 9 1.9 ± 0.3 191 ± 12 2.5 ± 0.4 64 ± 4 0.8 ± 0.1
CHO-EM 2881 ± 213 444 ± 33 6.1 ± 0.6 75 ± 6 1.0 ± 0.1 97 ± 7 1.3 ± 0.1
CHO-ER 1735 ± 246 267 ± 37 3.7 ± 0.7 45 ± 6 0.6 ± 0.1 59 ± 8 0.8 ± 0.2
Table 5
Taqman Assays on Demand information (Applied Biosystems).
Gene name Gene abbreviation Assay on Demand number
Silent information regulator-T1 (SIRT1) SIRT1 Hs01009005_m1
Silent information regulator-T3 (SIRT3) SIRT3 Hs00953477_m1
AMP-activated protein kinase 1 (AMPK) PRKAA1 Hs01562315_m1
Peroxisome proliferator-activated
receptor gamma coactivator 1-alpha (PGC-1a)
PPARGC1 Hs01016719_m1
Peroxisome proliferator-activated receptor delta (PPARd) PPARd Hs00987011_m1
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) GAPDH Hs99999905_m1
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method applieddirectly by theRoche software to the real-timeampliﬁcation curves. This value represents
the cycle atwhich the increase ofﬂuorescence is highest andwhere the logarithmicphase of a PCRbegins.
Ampliﬁcation Efﬁciency of qPCR assays: The efﬁciency of each of the Taqman® assays on demand
was conﬁrmed by performing standard curves in a 384 well qPCR assay on the LightCycler® 480 under
the same conditions as already described. Six point standard curves with 1 in 10 serial dilutions were
prepared in nuclease free water for human plasmid DNA for each of the genes being tested alongside
Human genomic DNA with a top concentration of 3e5 copies/mL and 1e5 copies/mL respectively. qPCR
reactions were performed in triplicate and the ampliﬁcation efﬁciency calculated for each Taqman®
assay on the basis of the equation E ¼ (10e1/slope 1)  100 with the logarithm of the template
concentration on the x axis and the average Cp plotted on the y axis.
2.10. Statistical analysis
KolmogoroveSmirnov tests of normality to assess the null hypothesis that data for within-subjects
analysis was normally distributed. Mauchly's sphericity test was used to assess the assumption of
sphericity within repeated-measures effects. Unless stated otherwise Mauchly's test was insigniﬁcant
(p > 0.05), therefore the assumption of sphericity was accepted.
The muscle biopsy qPCR analysis raw Cp values were normalised to the housekeeper gene (GAPDH)
using an analysis of covariance method, before relative fold change over TP1 (baseline) were calculated
using 2DDCT.
mRNA data were analysed using a two factorial mixed design ANOVA (4 groups, 2 time points) with
dietary intake (between) and time point (within) as the main variables. Where a main time effect was
observed awithin group paired sample assessments was used to identify where the time effect was. For
dietary intake a Bonferroni post hoc test was used to identify the location of signiﬁcant interactions
between groups (dietary intake). Visit one (baseline) and visit two (pre) were used as control trials; a
paired sample t-test was run to determine a difference between the control trials. Where difference in
baseline-pre was observed a mean of the two values was used for post comparison (which is stated in
the text), where no difference was observed, the pre value was used for comparison. Pre-post inter-
vention time point change was analysed using a paired sample t-test.
Statistical signiﬁcance was set at p  0.05. Statistical analysis was conducted using the statistical
package for the social science software program (SPSS; version 22, IBM, Armonk, NY). All data are
presented mean ± SEM unless speciﬁed.
3. Results
3.1. Habitual dietary intake
No main effects were observed for habitual total calorie intake or macronutrient breakdown (Table
6). The mean daily caloriﬁc intake across all groups was 2340 ± 473 kcal$day1 (range 2192 ± 574 to
2423 ± 330 kcal$day1).
A total of 8 days dietary intake was collected over the 2 week prior visit 1 and visit 2; participants
were requested to record intake on 3 week days and 1 weekend day each week using the estimated
Table 6
Average daily habitual caloriﬁc intake and macronutrient breakdown for each group prior to intervention diet. (mean ± SD and
percentage (%) of total energy intake).
Mean daily calorie intake (kcal$day-1) CHO PRO FAT
g$day1 % g$day1 % g$day1 %
PRO-EM 2192 ± 173 232 ± 22 42.4 95 ± 6 17.2 86 ± 6 35.2
PRO-ER 2391 ± 133 267 ± 16 44.7 100 ± 8 16.7 93 ± 5 35.0
CHO-EM 2355 ± 152 274 ± 23 46.6 103 ± 9 17.5 89 ± 8 33.8
CHO-ER 2407 ± 107 307 ± 16 51.7 97 ± 7 16.0 84 ± 5 31.4
M. Furber et al. / Clinical Nutrition Experimental 14 (2017) 13e2520household measures method. (CHO ¼ carbohydrate, PRO ¼ protein, FAT ¼ fat). % ¼ percentage of di-
etary intake.
3.2. Gene expression
No signiﬁcant difference was observed between TP1 and TP2 in any of the genes, thus it can be
assumed that any post intervention changes observed were due to the intervention rather than the
internal variability of the measure.
The output of statistical analysis demonstrated no group time effects in any of the genes (PGC-1a:
f ¼ 0.900, p ¼ 0.494, SIRT1: f ¼ 1.022, p ¼ 0.447, AMPK: f ¼ 2.827, p ¼ 0.29, SIRT3: f ¼ 2.843, p ¼ 0.128
and PPAR: f ¼ 2.068, p ¼ 0.145). However a time effect was observed in some of the genes which
warranted further exploration to identify where the time difference existed (PGC-1a: f ¼ 6.020,
p ¼ 0.048, SIRT1: f ¼ 6.297, p ¼ 0.037, AMPK; f ¼ 15.263, p ¼ 0.005 and SIRT3: f ¼ 9.628, p ¼ 0.015).
Within the PRO-ER group a signiﬁcant pre-post intervention time point difference was observed in
PGC-1a (fold increase ¼ 1.27, p ¼ 0.0402), AMPK (fold increase ¼ 2.09, p ¼ 0.027), SIRT1 (fold
increase ¼ 1.50, p ¼ 0.026) and SIRT3 (fold increase ¼ 1.19, p ¼ 0.010) mRNA expression. No time point
gene expression changes were observed in any other dietary group (Fig. 2 AeE), or in the expression of
PPAR mRNA.
A signiﬁcant change in LMwas observed post intervention as were signiﬁcant group difference. Post
intervention 3 or the groups lost LM (p < 0.05) (Fig. 3A), the CHO-ER losing the greatest amount
(1.26 ± 0.14 kg), the PRO-ER losing 0.82 ± 0.3 kg and CHO-EM losing 0.53 ± 0.19 kg respectively.
LM was maintained in the PRO-EM group (0.21 ± 0.17 kg). The CHO-ER group lost signiﬁcantly more
LM than both the PRO-EM and CHO-EM groups (p < 0.05), no difference in LM was observed between
the PRO-ER and CHO-EM groups.
The PRO-ER and CHO-ER groups lost greater (p < 0.05) BM than both CHO-EM and PRO-EM (Fig. 3C)
respectively. No difference was observed between groups matched for energy intake. All groups
exhibited a signiﬁcant loss in FM (p < 0.01) post 7-days dietary intervention (Fig. 1B). The PRO-ER lost
the greatest amount of FM (0.99 ± 0.11 kg) and the CHO-EM group lost the least (0.50 ± 0.14 kg). The
difference between these two groups was the only signiﬁcant group difference observed (p < 0.05).
A reduction in BM was observed post intervention in all groups (p < 0.01, Fig. 3C). The PRO-EM
group lost the least BM (0.74 ± 0.24 kg) whereas the CHO-ER lost the greatest (2.21 ± 0.17 kg).
Signiﬁcant post intervention group differences were observed (p < 0.01), this was not seen in grouped
matched for energy intake, however both ER groups lost signiﬁcantly more BM than EM groups.
No time or group interaction effects were observed in RMR (Table 7). Mean RMR across all groups
pre was 1910 ± 180 kcal vs. 1894 ± 184 post intervention.
4. Discussion
This is the ﬁrst acute dietary intervention study in healthy sedentary males to demonstrate that
increased dietary protein intake in a hypocaloric state positively increases upstream transcriptional
markers of mitochondrial biogenesis.
Under conditions of acute metabolic stress such as restricted energy availability and/or restricted
carbohydrate availability cellular metabolic processes need to adapt to accommodate energy demand
Fig. 2. Effect of feeding 7-days diet intervention on mRNA expression at rest. Effect of 7-days high protein energy matched (PRO-
EM), high protein energy restricted (PRO-ER), high carbohydrate energy matched (CHO-EM) or high carbohydrate energy restricted
(CHO-ER) diet in healthy lean individuals on PCG-1a (A), AMPK (B), SIRT1 (C), SIRT3 (D) and PPAR (E) mRNA expression. Muscle
samples were obtained following an overnight fast prior to the intervention and repeated again following 7-days dietary inter-
vention (Post). Values are expressed as fold change (pre to post) after normalization to the reference gene (GAPDH) and are reported
as the mean ± SE. For abbreviations of genes see Table 5. * ¼ signiﬁcant pre-post difference within group, p < 0.05.
M. Furber et al. / Clinical Nutrition Experimental 14 (2017) 13e25 21[18]. Both acute (<24 h) calorie reduction and carbohydrate restriction have independently been
shown to increase transcriptional markers of mitochondrial biogenesis in vitro [3], and it has been
suggested that these are key external regulators which can trigger mitochondrial biogenesis [13]. It has
also been suggested that in long term (>4 weeks) calorie restriction activates AMPK and SIRT1 as an
adaptive process to meet energy demands be increasing fat metabolism [15], however acute (7-day)
intervention used in this study does not support this. No change in mRNA expression in the PRO-EM
Fig. 3. Effect of either 7-days continuous high protein energy matched (PRO-EM), high protein energy restricted (PRO-ER), high
carbohydrate energy matched (CHO-EM) or high carbohydrate energy restricted (CHO-ER) diet on lean mass (kg) (A), fat mass (kg)
(B) and body mass (kg) (C) at rest in lean healthy individuals. The data presented as mean ± SEM; * denotes signiﬁcant difference
between PRO-EM and PRO-ER, ** denotes signiﬁcant difference between CHO-EM and CHO-ER, # denotes signiﬁcant difference
between PRO-EM and CHO-ER and ## denotes signiﬁcant difference between PRO-ER and CHO-EM. (p < 0.05).
Table 7
Resting metabolic rate (RMR) (kcal$day1) pre and post 7-day dietary intervention (Mean ± SEM).
RMR PRE (kcal$day1) RMR POST (kcal$day1)
PRO-EM 1916 ± 73 1910 ± 70
PRO-ER 1904 ± 37 1950 ± 54
CHO-EM 1972 ± 38 1946 ± 44
CHO-ER 1848 ± 69 1768 ± 52
M. Furber et al. / Clinical Nutrition Experimental 14 (2017) 13e2522(carbohydrate restriction) or CHO-ER (calorie restriction) groups was observed, suggesting that acute
(7-day) carbohydrate restriction and energy restriction independently, do not exert sufﬁcient meta-
bolic stress to elicit metabolic changes at transcriptional level. Importantly though, the results from
this study showed that subsequent to a continuous, hypocaloric high protein diet low carbohydrate
diet (40% protein (~2.5 g$kg1$day1) and ~33% energy deﬁcit) a small, but signiﬁcant, increase in
resting mRNA expression of AMPK, SIRT1, SIRT3 and PGC-1a in the vastus lateralis muscle was
observed. Implying that, in contrast to independent restriction, the combination of high protein low
carbohydrate diet (carbohydrate restriction) and calorie restriction may provide sufﬁcient metabolic
stress to elicit skeletal muscle adaptation. It is important to recognise that no group differences in
mRNA expression was observed in this study (AMPK p ¼ 0.056, PGC-1a p ¼ 0.063, SIRT1 p ¼ 0.801,
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adaptive response relative to other diets, however after running post-hoc power analysis the output
suggests the study may be slightly under powered which could explain the non-signiﬁcant ﬁndings.
Work from [3] and [6] have demonstrated signiﬁcant enhances metabolic function in response to high
fat low carbohydrate feedings. A 5-day hypocaloric HF/LC diet positively increased phosphorylation of
AMPK and deacetylation of PGC-1a, whereas the hypocaloric LF/HC diet negatively reduced the
phosphorylation of AMPK and deacetylation of PGC-1a [6]. These results, along with the ﬁndings from
the current study suggest that high carbohydrate intake prevents the activation of the AMPK-SIRT1 axis
that is otherwise observed in a hypocaloric state. Furthermore, and importantly the method of car-
bohydrate restriction does not seem important, increasing both dietary fat and/or protein result in
similar up-regulation of metabolic markers of mitochondrial biogenesis. A limitation of the gene
analysis chosen within this study is that the transcriptional mRNA measured are upstream markers of
adaptation, they demonstrate the potential to adapt. Adaptation per se was not directly assessed.
Subsequent to a hypocaloric diet ~70% of weight lost is attributed to FM and 30% from LM [37] and
weight loss strategies which promote LM maintenance and increased FM loss are deemed preferential
[24]. One such strategy previously suggested to promote LM maintenance during dietary restriction is
increasing dietary protein intake [16], reported increased FM loss and improved maintenance of lean
mass in obese womenwith increased protein intake (1.6 g$kg1$day1 vs. 0.8 g$kg1$day1). Within a
healthy non-obese male population the results from this study demonstrate similar ﬁndings. Although
there was no difference in body composition changes between energy-matched groups. When
matched for macronutrient ratio and manipulating energy intake the CHO-ER group lost signiﬁcantly
more LM than the CHO-EM group and no difference in LMwas observed between the PRO-ER and PRO-
EM. Suggesting that when restricting energy intake but maintainingmacronutrient ratio a high protein
low carbohydrate diet provides a sparing effect on leanmass loss relative to a high carbohydrate energy
restricted diet. Similarly to the mRNA data, visually the body composition data suggests a group dif-
ference in energy matched groups may exist, but no statistical signiﬁcance is identiﬁed, suggesting the
study may be underpowered. When cross-examining all groups, the PRO-ER group had a lower calorie
intake (~33% less kcal$day1 than CHO-EM group) and higher protein intake relative to the CHO-EM
group (2.5 g$kg1$day1 vs. 1.0 g$kg1$day1) but no change in LM was observed between groups,
suggesting a key role for protein in LM maintenance. The mechanism supporting increased dietary
protein in LM maintenance is still not fully deﬁned, however it has been demonstrated the proteolysis
of skeletal muscle is suppressed when consuming 1.5 g$kg1$day1 of protein [26]. The dietary
protein intake of the CHO-EM (1.0 g$kg1$day1) groupwas greater than the current reference nutrient
intake in the UK for adults of 0.75 g$kg1$day1 [7], however was below the 1.5 g$kg1$day1 sug-
gested by [26], the PRO-ER group consumed 2.5 g$kg1$day1 of protein, signiﬁcantly above this
threshold.
With regards to weight loss, although non-signiﬁcant, the results suggest a number of trends which
warrant further exploration. When consuming a hypocaloric diet, dietary protein intake could posi-
tively impact LM and FM ratios. When looking and components of BM lost while following the
continuous hypocaloric diet (~33% energy deﬁcit) both groups (high protein, low carbohydrate and
high carbohydrate) lost a signiﬁcant amount of LM, approximately 44% of total BM loss in the PRO-ER
groupwas attributed to LM loss compared to 56% in the CHO-ER group. This was coupled with a greater
percentage of FM loss in the PRO-ER group (56% vs. 44% respectively). As such, it could be assumed that
the increased dietary protein intake in the PRO-ER group (2.5 g$kg1 vs. 0.6 g$kg1) attenuated LM loss
by ~12% relative to a hypocaloric diet low in protein. A recent meta-analysis [41] investigating the role
of dietary protein intake and long term body composition changes (12 ± 9 weeks) concluded higher
protein diets led to greater BM loss (0.79 kg), FM loss (0.87 kg) and preserved more LM (þ0.43 kg)
relative to lower protein diets. Although over a shorter period, the body composition results from the
hypocaloric groups observed in this study followed the same trends with 0.35 kg BM, 0.09 kg FM
andþ0.44 kg LM body composition changes observed. The acute dietary interventionwithin this study
did not change in RMR and no time point difference or group interaction was observed in RMR.
Although it has been demonstrated that a positive curvilinear (r2 ¼ 0.92) relationship exists between
LM and RMR [38], and RMR is known to decline during prolonged (>9 months) periods of energy
restriction [11]. Even though protein has a greater thermic effect compared with the equivalent energy
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was not long enough to elicit changes in RMR, as such metabolic rate is not impacted by such a short
dietary intervention.
A marked reduction in RER post intervention was observed in both ER groups; however caution
should be takenwhen drawing strong conclusions from this data. Pre intervention both ER groups had
a higher RER (PRO-ER ¼ 0.89, CHO-ER ¼ 0.85, PRO-EM ¼ 0.83, CHO-EM ¼ 0.83) and post intervention
all groups had an RER of 0.79. Thus a greater relative change was observed pre-post intervention in the
ER groups, but no group interactionwas apparent. In mice and subsequent to 8 weeks on a hypocaloric
diet a signiﬁcant reduction in RER was observed compared to relative to energy matched diets [31].
Similar to the results from this study, RER was reduced to the same level in the hypocaloric group's
independent of dietary protein intake (5% vs. 33% vs. 60%). [31] also reported a signiﬁcant reduction in
RER in the eucaloric high protein group relative to the eucaloric high protein diet, however this was not
to the amplitude of the any of the hypocaloric diets. This suggests that in an eucaloric state restricted
carbohydrate (increased protein intake) results in a reduction in RER, however calorie restriction has a
greater metabolic impact, independent on macronutrient ratio.
Interestingly this study raises further considerations for dietary prescription studies and methods
used to measure energy intake. Despite meticulous effort to match the dietary intake of the PRO-EM
and CHO-EM to energy expenditure the results demonstrated a small reduction in BM in both group
(0.74 kg and 1.1 kg respectively), as such dietary prescription was slightly underestimated. The mean
calorie intake calculated from 2  4 day food diaries for each participant in the PRO-EM and CHO-EM
groups were 2192 ± 574 kcal$day1 and 2355 ± 527 kcal$day1, respectively. Using a tightly controlled,
and previously though as robust, method of calculating energy expenditure (energy
expenditure ¼ RMR  Activity Factor, where RMR was calculated using indirect calorimetry) dietary
intake for the two EM groups were 2828 ± 331 kcal$day1 and 2881 ± 213 kcal$day1; a difference of
636 and 526 kcal$day1 compared to food diary analysis. Suggesting that habitual diet recorded using
estimated household measures under predicted energy intake calculated using RMR  Activity Factor
by ~20% which is similar to previous ﬁndings in athletes [19] (~28%) and sedentary participants [34]
(~20%). Furthermore, dietary prescription using RMR  Activity Factor resulted in a mean BM loss
0.92 kg across both groups in 7-days, suggesting an even greater under prediction of energy expen-
diture using this equation.
5. Conclusions
This is the ﬁrst study to demonstrate the impact of increased protein intake in a hypocaloric diet on
metabolic adaptation. The results from this study demonstrated that a 7-day a high protein hypocaloric
diet resulted in increased AMPK, SIRT1, SIRT3 and PGC-1a mRNA expression at rest, however no be-
tween group effect was observed. Additionally when maintaining macronutrient ratio and reducing
energy intake, a high protein diet attenuated LM loss this was not seen following a high carbohydrate
diet energy restricted diet. Further larger studies are required to investigate these effects further,
additionally future research is needed to understand the long-term impact of a high protein hypo-
caloric diet on markers of mitochondrial biogenesis and body composition.References
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